Article
XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Diagnostic pathology - 19 Jun 2014
Peng Qiliu, Lao Xianjun, Tang Weizhong, Chen Zhiping, Li Ruolin, Qin Xue, Li Shan
Abstract excerpt
BACKGROUND: Published studies investigating the association between XPC Lys939Gln polymorphism and colorectal cancer (CRC) risk reported inconclusive results. We performed a meta-analysis to derive a precise estimation of the relationship. METHODS: A comprehensive literature search was done in databases PubMed, EMBASE, and Cochrane library up to December 2013. The association between XPC Lys939Gln polymorphism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
